https://www.selleckchem.com/pr....oducts/ldc195943-imt
0001, for both). Mean hospital stay ( = .002) and umbilical cord pH ( .05) were higher among those who received TxA prophylaxis than in those who were not treated. The finding of our study suggest that prophylactic administration of TxA prior to CS improves maternal and neonatal outcomes. The finding of our study suggest that prophylactic administration of TxA prior to CS improves maternal and neonatal outcomes. To review the evidence around self-management interventions used to improve mobility post-stroke. An integrative
Like
Comment
Share
